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Mammalian cancers depend on ‘‘multiple hits,’’ some
of which promote growth and some of which block
apoptosis. We screened for mutations that require
a synergistic block in apoptosis to promote tissue
overgrowth and identified myopic (mop), the
Drosophila homolog of the candidate tumor-
suppressor and endosomal regulator His-domain
protein tyrosine phosphatase (HD-PTP). We find
that Myopic regulates the Salvador/Warts/Hippo
(SWH) tumor suppressor pathway: Myopic PPxY
motifs bind conserved residues in the WW domains
of the transcriptional coactivator Yorkie, and Myopic
colocalizes with Yorkie at endosomes. Myopic
controls Yorkie endosomal association and protein
levels, ultimately influencing expression of some
Yorkie target genes. However, the antiapoptotic
gene diap1 is not affected, which may explain the
conditional nature of the myopic growth phenotype.
These data establish Myopic as a Yorkie regulator
and implicate Myopic-dependent association of
Yorkiewith endosomal compartments as a regulatory
step in nuclear outputs of the SWH pathway.
INTRODUCTION
The link between unrestrained proliferation and the evasion of
apoptosis in vertebrate tumors is well established (e.g., Evan
and Vousden, 2001). Many growth-promoting lesions such as
amplification of c-Myc or the loss of Rb trigger compensatory
apoptosis, which must then be overcome by antiapoptotic
lesions in order for tumorigenesis to proceed. Many of the
molecular mechanisms that drive tumorigenesis are conserved
in Drosophila melanogaster, and in recent years, Drosophila
has proven itself amenable to the study of cooperatingmutations
that drive tumor progression and metastasis (Brumby and
Richardson, 2005; Chi et al., 2010; Pagliarini and Xu, 2003; Wu
et al., 2010). In some cases, this cooperativity has been shown
to arise from synergistic effects on cell proliferation and death
pathways (Asano et al., 1996; Nicholson et al., 2009; Pellock
et al., 2007; Staehling-Hampton et al., 1999), yet the extent to700 Developmental Cell 20, 700–712, May 17, 2011 ª2011 Elsevier Inwhich compensatory apoptosis has hindered the identification
of a conditional class of growth suppressor genes in Drosophila
has not been comprehensively examined.
The conserved Salvador/Warts/Hippo (SWH) pathway
controls a transcriptional program that includes both progrowth
and antiapoptotic targets (Halder and Johnson, 2011; Pan,
2010). Pathway components include the protocadherin Fat, the
apical membrane determinant Crumbs (Crb), and the FERM-
domain proteins Expanded (Ex) and Merlin (Mer) (Bennett and
Harvey, 2006; Chen et al., 2010; Cho et al., 2006; Grzeschik
et al., 2010; Hamaratoglu et al., 2006; Ling et al., 2010; Robinson
et al., 2010; Silva et al., 2006;Willecke et al., 2006). These factors
regulate a core serine/threonine kinase cassette consisting of the
Ste20-like kinaseHippo (Hpo) (Harvey et al., 2003; Jia et al., 2003;
Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003), which
acts together with the scaffolding protein Salvador (Sav) (Kango-
Singh et al., 2002; Tapon et al., 2002) to phosphorylate the NDR
family kinase Warts (Wts) (Justice et al., 1995; Xu et al., 1995).
Wts then (Lai et al., 2005) phosphorylates the cotranscriptional
activator Yorkie (Yki) on sites including Ser168 (S168) (Dong
et al., 2007; Huang et al., 2005). This modification anchors Yki
in the cytoplasm by recruiting 14-3-3 proteins (Oh and Irvine,
2008). In the absence of SWH signaling, Yki shuttles into the
nucleus and, together with sequence-specific DNA binding
factors (Goulev et al., 2008; Peng et al., 2009; Wu et al., 2008;
Zhang et al., 2008; Zhao et al., 2008), activates a transcriptional
program including the progrowthmicroRNA bantam, the prodivi-
sion gene cyclin E (cycE), the antiapoptotic gene diap1, and the
upstream regulators ex andmer.
The SWH pathway has potent antigrowth activity (for review,
see Pan, 2010; Zhao et al., 2010), andmultiple mechanisms exist
to limit Yki activity in developing tissues. While S168 is critical for
Yki:14-3-3 binding, Wts phosphorylation of S111 and S250 also
contribute to Yki inhibition (Oh and Irvine, 2009; Ren et al.,
2010). Yki is directly inhibited in a phosphorylation-independent
manner via interactions between two WW domains within Yki
that are bound by PPxY sequence motifs in Hpo, Wts, and Ex
(Badouel et al., 2009; Oh et al., 2009). Mammalian cells have
additional regulatory mechanisms to control activity of the Yki
homolog Yes-associated protein (YAP). YAP is tyrosine phos-
phorylated by c-Src/Yes kinases, which modulates the ability of
YAP to recruit the Runx2 protein and control osteoblast differen-
tiation (Zaidi et al., 2004). DNA damage triggers the c-Abl kinase
to phosphorylate YAPonY357, and thismaybias YAP toward the
promoters of apoptotic genes over growth-arrest genes (Levyc.
Figure 1. An eyFLP Mosaic Screen for
Conditional Growth Suppressors
(A) Clones of cells carrying EMS-induced muta-
tions (*) in the background of the H99,FRT80B
chromosome were generated using the eyFLP
transgene. Homozygous *H99,FRT mutant cells
are marked by the absence of the P[mw+]
transgene, andwild-type twin spots aremarked by
the presence of P[mw+].
(B–E) Representative images of H99 alone (B),
sfvH99 (C), control FRT80B (D), and sfvFRT80B (E)
mosaic adult eyes.
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mutations in peripheral SWH pathway components may selec-
tively affect the transcriptional specificity of nuclear Yki.
Here, we apply a genetic approach to identify conditional
growth suppressor mutants and identify Myopic (Mop) as
aprotein that physically interactswith Yki and restricts its activity.
mop is a homolog of human His-domain protein tyrosine phos-
phatase gene (HD-PTP or PTPN23) (Toyooka et al., 2000), which
is located in a region of the genome frequently deleted in cancers
(Braga et al., 2002; Kok et al., 1997; Szeles et al., 1997). Mop and
HD-PTP proteins contain an amino-terminal Bro1 domain and
a carboxy-terminal domain with sequence homology to protein
tyrosine phosphatase (PTPase) domains. HD-PTP interacts
with endosomal proteins such as CHMP4b via the Bro1 domain
and interacts with the ESCRT-1 component Tsg101 via sites
outside the Bro1 domain (Doyotte et al., 2008; Ichioka et al.,
2007; Kim et al., 2005; Miura et al., 2008; Odorizzi et al., 2003).
We find that cells lacking Mop display overgrowth phenotypes
only in the context of a block in cell death. This growth is accom-
panied by upregulation of a subset of Yki transcriptional targets
but not the antiapoptotic gene diap1. mop interacts genetically
with yki and acts downstream of wts, but at the level of ex and
yki. Mop protein colocalizes with Yki in endosomes and physi-
cally interacts with Yki via PPxY motifs in Mop and WW domains
in Yki. Moreover, loss ofmop shifts the endosomal localization of
endogenous Yki and elevates Yki protein levels. These data
identifyMop as an inhibitor of Yki in developing tissues and impli-
cate Mop-dependent control of Yki-containing endosomalDevelopmental Cell 20, 700–complexes as a SWH regulatory mecha-





We designed and implemented a screen
for survival-dependent growth sup-
pressor genes on Drosophila chromo-
some 3L. The screen used FLP recombi-
nase driven by the promoter of the
eyeless (ey) gene (Newsome et al., 2000)
to produce a mixture of mutant clones
(unpigmented) and wild-type twin spots
(pigmented red) in the adult eye (Fig-
ure 1A). To block cell death in mutantclones, mutagenesis was carried out using a parental FRT chro-
mosome carrying the genomic deletion H99, which removes
genes required for virtually all developmentally programmed cell
death (White et al., 1994). H99 mutant clones display a block in
developmental apoptosis in the pupal retina (30 hr after puparium
formation [APF]) (see Figures S1A and S1A0 available online) and
exhibit minimal phenotypes in the adult eye (Figures 1B versus
1D). We used this background to screen for recessive mutations
that could synergize with H99 to confer a growth advantage and
identified a recessive-lethal complementation group, which we
named slaughterhouse-five (sfv), consisting of two alleles
(F2.6.3 and F2.6.11) that exhibited a clonal growth advantage in
the adult eye (Figure 1C) relative to an H99 control. Experiments
were carried out with the sfv3 allele (F2.6.3) unless otherwise
indicated. To test the survival-dependent nature of the sfvpheno-
type, the H99 deletion was removed. Adult sfv mosaic eyes are
small and rough and contain little to no sfv mutant tissue (Fig-
ure 1E). Clones of sfv mutant cells in the larval eye disc contain
elevated levels of cleaved caspase-3 (C3) (Figures S1B and
S1B0), indicating they are normally eliminated by apoptosis.
Thus the overgrowth of sfvmutant cells is conditional on a syner-
gistic block in cell death provided by the H99 deletion.
sfv Is Allelic tomyopic, the Drosophila Homolog
of HD-PTP
The sfv lesions were mapped by deficiency mapping and candi-
date gene sequencing. This identified a nonsensemutation in the
seventh exon of the gene CG9311 on the sfv3 chromosome. The712, May 17, 2011 ª2011 Elsevier Inc. 701
Figure 2. mop Loss Cooperates with a Block in Death to Increase
Organ Size
(A and B) Bright-field images of control H99/M(3) (A) and mopsfvH99/M(3) (B)
eyes/heads.
(C and D) Scanning electron micrographs (SEM) of control H99/M(3) (C) and
mopsfvH99/M(3) (D) eyes/heads.
(E and F) SEM of H99 (E) and mopsfvH99 (F) clones in adult thoraces.
mopsfvH99 mutant tissue is marked by dashes (/).
(G and H) Images of mosaic H99 (G) and mopsfvH99 (H) halteres.
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Drosophila homolog of vertebrate HD-PTP. The sfv3 mutation
truncates Mop within its C-terminal region, just prior to the
PTPase catalytic region (Figure S1H). The lesion in the sfv11 allele
was not identified, but staining with an anti-Mop antibody shows
reduced Mop protein levels in both sfv3H99 and sfv11H99 eye
clones (Figures S1C and S1C0; data not shown), indicating that
both sfv alleles reduceMop expression. The sfv3 and sfv11 alleles
fail to complement existingmop alleles (data not shown) and will
be referred to as mopsfv3 and mopsfv11.
Mop/HD-PTP is a conserved endosomal regulatory protein
that contains an N-terminal Bro1 domain and a C-terminal pre-
dicted PTPase domain. The PTPase domain lacks activity
in vitro due to an amino acid change in the phosphate-binding
loop that diverges from all other active PTPases (Gingras et al.,
2009), and this change is conserved in Mop. The Mop Bro1
domain is required to promote the endocytic trafficking and
activity of the EGF and Toll receptors (Huang et al., 2010; Miura
et al., 2008) and defects in differentiation of Elav-positive
neurons within mop eye clones have been attributed to a defect
in EGF signaling (Miura et al., 2008). However, some Elav-posi-
tive cells remain in mopsfvH99 clones (Figures S1D and S1E),
and the R2/R5 photoreceptor marker Rough is increased in
mopsfvH99 clones relative to mopsfv clones (Figures S1F and
S1G). Thus, the lack of photoreceptors in mop mutant clones
may be due to excess apoptosis and impaired EGF-dependent
photoreceptor recruitment.
mop Mutations Collaborate with a Block in Cell Death
to Elicit Organ Overgrowth
Genetic manipulations that simultaneously increase proliferation
and reduce apoptosis often increase organ size. To test the
effect of the mopsfvH99 genotype on organ size, the recessive
cell-lethal Minute technique was used to generate heads
composed entirely of mopsfvH99 cells (mopsfvH99/M(3)). These
animals die at the pharate adult stage with extra folds of head
cuticle relative to control heads and eyes that are constricted
at their margins and protrude from the head (Figures 2A–2D)
and contain enlarged facets (data not shown). Generation of
mopsfvH99 clones throughout the body produced outgrowths
in the adult thorax (Figures 2E and 2F) and increased haltere
size (Figures 2G and 2H) relative to H99 controls. Thus,
combined loss of Mop and the H99 proapoptotic genes
increases the growth of multiple types of epithelia.
mop Loss Increases Cell Proliferation Rates and Inhibits
Cell-Cycle Exit
The synergy betweenmopsfv and H99 alleles indicates thatmop
loss may increase cell number, conditional on a block in
apoptosis. Staining with anti-Discs large (Dlg) to mark apical
cell profiles reveals excess interommatidial cells (IOCs) in
mopsfvH99 pupal eye clones relative to H99 mutant clones
(Figures 3A and 3B). Patterning defects are also evident within
mopsfvH99 mutant pupal clones, which may be a consequence
of additional roles for Mop in cell fate pathways (e.g., Miura
et al., 2008). Scattered ectopic S phase cells appear among
mopsfvH99 mutant cells posterior to the second mitotic wave
(SMW) (Figures 3C–3F), which normally marks the point at which
cells become postmitotic (Wolff and Ready, 1993); this pheno-702 Developmental Cell 20, 700–712, May 17, 2011 ª2011 Elsevier Intype is not evident in H99 control clones (Figure 3D). mopsfvH99
mutant eye clones also show a perdurance of cyclin A and, to
a lesser extent, cyclin E, posterior to the morphogenetic furrow
(MF) (Figures 3G–3L). To test whether mop limits cell division,
the rate of clonal expansion of H99 and mopsfvH99 clones
were analyzed in the wing disc epithelium at fixed time points
after clonal induction. mopsfvH99 clones are consistently larger
and contain more cells than wild-type ‘‘twin spots’’ or control
clones homozygous for the H99 deletion (Figures 3N and 3O);
the boundaries of mopsfvH99 clones tend to be regular (Fig-
ure 3M, top left panel), suggesting that mop loss may affect
cell adhesion. Fluorescence-activated cell sorting (FACS) anal-
ysis of mopsfvH99 and H99 wing disc cells relative to a control
ubi > GFP chromosome indicates that mopsfvH99 cells have
a DNA-content profile and size similar to H99 control cells (Fig-
ure 3M). Thus, although mopsfvH99 mutant cells proliferate
more rapidly than control cells, this is not accompanied by an
overall shift in cell-cycle phasing.
mop Promotes SWH Signaling and Functions
Downstream of the Core SWH Kinase Cassette
The mopsfvH99 mutant growth phenotypes resemble those
associated with Sav/Wts/Hpo (SWH) pathway mutants (forc.
Figure 3. mop Limits Cell Division
(A and B) Confocal images of H99 (A) and mopsfvH99 (B) pupal eye clones
(40 hr APF) stained with anti-Dlg.
(C–L) Images of H99 (C and D) or mopsfvH99 (E–L) eye clones marked by the
absence of GFP (green) and stained for BrdU incorporation (C–F), Cyclin A
(G–I), or Cyclin E (J–L). The morphogenetic furrow (MF) is marked by an
arrowhead in (C)–(L). Yellow arrows in (H) denote perdurance of Cyclin A
posterior to theMF. Yellow arrow in (K) denotes perdurance of Cyclin E in basal
nuclei posterior to the MF.
(M) Confocal image of a mopsfvH99 mutant wing clone (black, /) and its
wild-type twin spot (white) and corresponding flow cytometric analysis of DNA
content and cell size (‘‘FSC’’; see inset) in H99/M(3) (gray fill) and mopsfvH99/
M(3) (black line) early third instar wing discs.
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Devereview, see Pan, 2010). We therefore tested the effect of mop
alleles on expression of SWH target genes and proteins. Expres-
sion of the ex-lacZ transcriptional reporter (ex-Z) is upregulated
in apically located mopsfvH99 mutant cells posterior to the MF
(Figures 4A and 4A0); this effect is most apparent in transverse
sections of peripodial cells (Figures 4B and 4B0) but is also
detectable by qRT-PCR analysis of ex mRNA in intact discs.
Ex protein levels are increased in tangential (Figures 4C and
4C0) and transverse (Figures 4D and 4D0) sections of mopsfvH99
clones. Control H99 clones have no effect on ex-Z or Ex (Figures
S2A, S2A0, S2B, S2B0, S2C, and S2D). mopsfvH99 mutant disc
cells accumulate the apical membrane protein Crb (Figures 4E
and 4F), which occurs in wts mutant cells via a Yki-dependent
mechanism (Genevet et al., 2009; Hamaratoglu et al., 2009).
Wg protein accumulates in mopsfvH99 clones located in the
hinge and notum regions of the larval wing (Figures 4G and
4H), which also occurs in some SWH mutants (Cho et al.,
2006; Hamaratoglu et al., 2006; Maitra et al., 2006; Pellock
et al., 2007). Expression of a mop inverted repeat (UAS-mopIR)
transgene in the posterior wing disc reduces expression of the
bantam-GFP sensor (ban-GFP) (Figures 4I and 4J), indicating
that levels of the ban miRNA (Oh and Irvine, 2011) are elevated
in Mop-depleted cells. Parallel analysis of the effect of mopIR
on epitope-tagged Yki (Yki:V5) (Oh and Irvine, 2009) shows
that knockdown of mop causes Yki:V5 to accumulate in the
cell cytoplasm (Figures S2I and S2J). Consistent with an in-
hibitory role for Mop in the SWH pathway, heterozygosity for
a yki mutant allele efficiently suppressed the overgrowth of
mopsfvH99/M(3) eyes and heads (Figures 4K and 4L). Thus,
although Mop loss does not stabilize Yki in the nucleus, its effect
on the expression of SWH targets and its genetic dependence on
a diploid dose of yki argues that the mopsfvH99 growth pheno-
type is mediated at least in part by elevated Yki activity.
Genetic analysis was used to placemop into a functional hier-
archy with other SWH pathway genes. Expression of Wts
suppresses disc growth (Lai et al., 2005; Wei et al., 2007), yet
overexpression of Wts in the mopsfvH99/M(3) background has
no effect on the size or morphology of pharate adult heads
(Figures 4M and 4N). By contrast expression of full-length Ex
(either UAS-Ex or UAS-Ex:GFP), which can act downstream of
Wts via direct binding to Yki (Badouel et al., 2009), suppresses
the size of mopsfvH99/M(3) heads (Figures 4O and 4P). The C
terminus of Ex (CT:GFP), which contains PPxY motifs that bind
Yki, is a more potent suppressor of the mopsfvH99/M(3) growth
phenotype than full-length Ex:GFP, while the control linker
domain of Ex (linker:GFP) has no effect on mopsfvH99/M(3)
heads (Figures S2K–S2P). CT:GFP had only a slight effect on
the size of control heads, indicating that loss of mop sensitizes
cells to elevated levels of Ex. To test synergy between Mop
and Ex loss, these factors were knocked down individually or
in combination in the developing eye using UAS-exIR and
UAS-mopIR transgenes. While exIR ormopIR individually produce
amild increase in IOCs in the pupal eye, combined expression of
both enhances the IOC phenotype (Figures 4Q–4T). This genetic
interaction between Mop and Ex in control of IOC numbers(N and O) Cell number in individual H99 (N) or mopsfvH99 (O) clone:twin spot
pairs. Data are arranged in order of increasing clone size. Variation in
mopsfvH99 cell counts is due to position-specific effects in the wing.
lopmental Cell 20, 700–712, May 17, 2011 ª2011 Elsevier Inc. 703
Figure 4. mop Promotes SWH Signaling and Is Epistatic to warts
(A–H) Confocal images of mopsfvH99 clones (marked by the absence of GFP) in the larval eye (A–F) or wing (G and H) analyzed for expression of ex-lacZ (ex-Z)
(optical section in A and A0 and transverse section in B and B0), Ex (optical section in C and C0 and transverse section in D and D0), Crb (transverse section in E
and F), or Wg (G and H). Stars in (F) denote increased apical Crb in mopsfvH99 clones. Arrows in (H) denote increased Wg protein in mopsfvH99 clones in the
proximal wing and the notum.
(I and J) Confocal images of bantam activity (visualized by ban-GFP) in control en > Gal4 (I) and en > Gal4,mopIR (J) discs. Dashed line denotes A:P boundary.
(K–P) Bright-field images ofmopsfvH99/M(3) control heads (K, M, and O) andmopsfvH99/M(3) heads that are either heterozygous for the ykiB5 allele (L), expressing
UAS-Wts (N), or UAS-Expanded (full-length) (P). The ykiB5/+ experiment was carried out with the mopsfv11 allele.
(Q–T) Confocal images of control GMR/+ (Q), GMR > exIR (R), GMR > mopIR (S), and GMR > exIR,mopIR (T) 48 hr APF pupal eye discs stained with Dlg (white).
Yellow arrows in (T) denote multilayered interommatidial cells in the exIR, mopIR double mutant.
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showmild IOC phenotypes when lost individually, but synergistic
effects when combined (e.g., Baumgartner et al., 2010; Genevet
et al., 2010; Ling et al., 2010; Yu et al., 2010).
Mop Interacts with Yki via Residues in the Yki WW
Domains
To identify the protein target of Mop within the SWH pathway, we
undertook an affinity purification/mass spectrometry (AP/MS)
analysis ofMop-containingcomplexes (Kyriakakis et al., 2008;Ve-
raksa et al., 2005) purified from cultured S2 cells. A form of Mop
with a point mutation in the putative PTPase catalytic domain
(C1728 to alanine; MopCS) was used for this analysis in order to
enhance interactions with endogenous proteins. This technique
identified 14 partially overlapping peptides derived from the
endogenous Yki protein (bolded in Figure 5A). Coimmunoprecipi-
tation (coIP) analysis fromS2cells expressingHA-Yki andMop-V5704 Developmental Cell 20, 700–712, May 17, 2011 ª2011 Elsevier Inconfirmed the interaction in the reciprocal orientation: HA-Yki is
able to efficiently coIP both MopCS and wild-type Mop (MopWT)
(Figures 5B and 5C). To study the Mop:Yki interaction further,
two conserved tyrosines (Y281 and Y350) within the Yki WW
domains (see Figure 5A) were individually altered to alanine (A)
(HA-YkiY281A and HA-YkiY350A). Mutation of an equivalent Y
residue within the WW domain of polyglutamine tract-binding
protein-1 (PQBP1) disrupts binding to PPxY-containing peptides
(Tapia et al., 2010). Although expressed at similar levels to HA-
Yki, both of the Y-to-A WW mutants are defective in binding to
MopWT andMopCS (Figures 5B and 5C). Mop contains two candi-
date PPxY motifs located in its linker region between the Bro1
domain and the PTPase-like domain (Figure 5D), indicating that
Mop may bind Yki via a WW:PPxY interaction module similar to
the interaction between the Yki WW domains and PPxY motifs in
Ex, Hpo, and Wts (Badouel et al., 2009; Oh et al., 2009). To test
this, each of the Mop PPxY motifs were changed to PPxAc.
Figure 5. Mop Physically Interacts with Yki via a WW:PPxY
Mechanism
(A) The Yki-PF isoform. Fourteen distinct, partially overlapping peptides
(indicated in bold) were recovered from affinity purification/mass spectrometry
analysis of MopCS-containing complexes. The WW domains of Yki are un-
derlined, and asterisks denote the conserved tyrosine residues required for the
Mop:Yki interaction (see below).
(B) Physical association between MopCS and Yki. Lanes 1–4: S2 cell lysates
expressing the indicated combination of MopCS-V5 and HA-Yki constructs
were immunoprecipitated and probed with the indicated antibodies.
(C) Physical association between MopWT and Yki. Lanes 1–4: S2 cell lysates
expressing the indicated combination of MopWT-V5 and HA-Yki constructs
were immunoprecipitated and probed with the indicated antibodies.
(D) Physical association between MopPPxY mutants and wild-type Yki. Lanes
1–4: negative control IPs of S2 cell lysates expressing the indicated Mop-V5
constructs. Lanes 5–8: S2 cell lysates expressing the indicated combination of
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Deve(PPxY1A, PPxY2A, or PPxY1,2A) and tested for Yki binding. The
Mop-PPxY1,2A mutant showed a loss of Yki binding, while each
single mutant showed minor residual binding (Figure 5D and
data not shown). Thus, Mop can bind to Yki via a WW:PPxY inter-
action mechanism that is conserved in other SWH proteins that
bind directly to Yki.Mop Inhibition of Yki Is Phosphorylation Independent
A version of Yki carrying serine-to-alanine mutations in threeWts
phosphorylation sites (S111A, S168A, and S250A; UAS-
yki:V5S3A) shows enhanced oncogenic activity due to a loss of
inhibitory phosphorylation by Wts (Oh and Irvine, 2009).
However, expression of Hpo, Wts, or Ex, which directly bind
the Yki WW domains via their PPxY motifs, are able to suppress
YkiS3A phenotypes (Oh et al., 2009). To test whether Mop can
also regulate Yki in a phosphorylation-independent manner,
UAS-yki:V5 or UAS-yki:V5S3A was coexpressed with Mop
(UAS-mop) in the larval eye. As reported, Yki:V5 shows little
effect on growth of the larval eye disc while Yki:V5S3A produces
enlarged disc with folds of excess tissue (Figures 5E and 5F).
Expression of Mop resulted in substantial suppression of the
Yki:V5S3A growth phenotype (Figure 5G). This ability of Mop to
antagonize a form of Yki that is refractory to SWH-mediated
phosphorylation is consistent with a model in which Mop inhibits
Yki directly via theWW:PPxY interaction. Significantly, heterozy-
gosity for mop enhances the progrowth effect of the human Yki
homolog Yap in the developing eye (Figures 5H–5J), suggesting
that the functional relationship between Yki and Mop-like
proteins may be conserved.mop Regulates Association of Yki with Endosomal
Compartments
Studies with HD-PTP indicate that the Mop N-terminal Bro1
domain may facilitate interactions with ESCRT endosomal
complexes (Doyotte et al., 2008; Ichioka et al., 2007; Odorizzi
et al., 2003) and that this underlies the ability of Mop to promote
signaling by the EGF and Toll receptors (Huang et al., 2010;
Miura et al., 2008). The finding that Mop sequences outside
the Bro1 domain bind Yki suggests that Mop may regulate the
association of Yki with specific endosome-associated protein
complexes, or that Mop physically links Yki to the endosomal
trafficking of a receptor-like SWH component such as Fat (for
review, see Reddy and Irvine, 2008). To test whether the
mopsfvH99 growth phenotype requires signaling downstream
of Fat, we expressed an RNAi knockdown transgene to approx-
imated (app), which is required for the overgrowth of mutant fat
tissue (Matakatsu and Blair, 2008), in the mopsfvH99/M(3)wild-type Yki and Mop-V5 constructs were precipitated and probed with the
indicated antibodies. A diagram of the Mop protein shows the location of the
two PPxY1791 and PPxY2823 sites.
(E–G) Phosphorylation-independent repression of Yki-driven overgrowth by
Mop. Confocal sections of eye imaginal discs expressing GMR-Gal4, UAS-
Yki:V5 (E), GMR-Gal4, UAS-Yki:V53SA(F), GMR-Gal4, UAS-Yki:V53SA + UAS-
Mop (G), and stained for V5 (red in E) or Yki (red in F and G) and with nuclei
labeled by YOYO-1 iodide (green).
(H–J) YAP-driven overgrowth is sensitive to the genetic dose ofmop. Scanning
electron micrographs (SEM) of GMR-Gal4, mop-/+ (H), GMR-Gal4/UAS-YAP
(I), and GMR-Gal4/UAS-YAP; mop +/ (J) adult eyes.
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Figure 6. Mop Controls the Endosomal Localization of Yki
(A–C) Confocal images of S2 cells expressing HA-Yki (A and A00 [red]) together with Mop-V5 (A–A00 [green]), or Yki:V5 (B–B00 and C–C00) together with GFP:Rab7
(B–B00) or GFP:Rab5 (C–C00).
(D and E) Confocal images ofmop dsRNA-treated S2 cells expressing Yki:V5 and either GFP:Rab5 (D–D00) or GFP:Rab7 (E and E0). Inmop dsRNA-treated S2 cells,
a portion of Yki:V5 is relocalized to large Rab5-positive endosomes (yellow arrowheads in D) and is excluded from enlarged Rab7-positive endosomes (green
arrowheads in E).
(F–K) Confocal sections ofH99 (F–H) andmopsfvH99 (I–K) mutant eye imaginal disc tissue, immunostained for endogenous Yki (red) and early endosome antigen-
1 (EEA1 [green]). Yki/EEA1 double-positive endosomes are marked by white arrows in (F) and (I) and red arrows in (H) and (K). Red arrows in (K) denote slightly
enlarged EEA1 endosomes in mop,H99 cells that also colocalize with Yki. Dashed boxes correspond to insets. Images were collected at 1003 magnification.
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mopsfvH99/M(3) heads, and reciprocally, loss of Mop had no
discernible effect on Fat levels or the degree of Fat colocalization
with the early endosomal marker EEA1 (Figures S2E–S2H), indi-
cating that mopsfvH99 may promote growth independent of
a defect in Fat signaling.
The effect ofmopIR onYki protein (see Figures S2I and S2J) led
us to examine the relationship betweenMop and the cytoplasmic
pool of Yki more closely. In imaginal discs and S2 cells, Mop is
normally found in cytoplasmic puncta adjacent to Rab5-positive
endosomes and partially colocalizes with Rab7-positive endo-
somes (Huang et al., 2010; Miura et al., 2008). To test whether
the physical interaction of Mop and Yki proteins is accompanied
by a colocalization of the proteins to specific cytoplasmic struc-
tures, HA-Yki and Mop-V5 were visualized in cultured S2 cells.
HA-Yki and Mop-V5 substantially colocalize to discrete puncta
in the cytoplasm (Figures 6A and 6A00). To identity these Yki-con-
taining structures, Yki:V5 was coexpressed with either GFP-
Rab7 or GFP-Rab5 to mark late and early endosomes, respec-706 Developmental Cell 20, 700–712, May 17, 2011 ª2011 Elsevier Intively. A majority of Yki:V5 protein localizes to Rab7-containing
late endosomes in S2 cells (Figures 6B–B00). This parallels the re-
ported partial location of Mop to Rab7 endosomes (Miura et al.,
2008) and indicates that Mop and Yki partially colocalize at these
structures. By contrast, Yki:V5 is largely excluded from Rab5-
containing early endosomes (Figures 6C and 6C00). To test
whether depletion ofmop affects these patterns, Yki:V5 was ex-
pressed with either GFP-Rab5 or GFP-Rab7 in cells treated with
mop dsRNA. As reported (Miura et al., 2008), depletion ofmop by
RNA interference caused an enlargement of GFP-Rab7 endo-
somes (Figures 6E and 6E00). These enlarged mop-knockdown
GFP-Rab7 endosomes are depleted for Yki:V5 relative to
untreated S2 cells (green arrowheads, Figures 6E and 6E00), and
in parallel, Yki:V5 appears in GFP-Rab5 endosomes (yellow
arrowheads, Figures 6D and 6D00). This endosomal redistribution
of exogenous Yki correlates with an increase in overall levels of
the protein and increased expression of the Yki target ex as
measured by qRT-PCR (Figures S3A and S3C). A similar rise in
endogenous Yki levels is observed upon mop knockdown in S2c.
Figure 7. Mop Exhibits Specificity in the Regula-
tion of Yki Activity
(A and A0 ) Confocal image of amopsfvH99mosaic eye disc
stained with an antibody to DIAP1.
(B) qRT-PCR analysis of diap1 and ex mRNA levels in wts
mosaic, H99/M(3), and mopsfvH99/M(3) eye imaginal
discs. P values were calculated using an unpaired t test,
and error bars represent standard deviation from themean
of two independent experiments performed in triplicate.
(C–G) Confocal images of wts mosaic eye discs (C, C0, D,
andD0 ), orwts discs withMARCM-mediated expression of
UAS-Mop (E, E0, F, and F0) or UAS-MopCS (G and G0)
stained for expression of ex-Z (C, C0, E, E0, G, and G0) or
th-Z (diap1) (D, D0, F, and F0). In all genotypes, wts clones
are positively marked by GFP (green).
(H) Model of the Mop:Yki interaction. The PPxY motifs in
Mop are shown, as are the Yki WW domains (green
squares). EE, early endosome; LE, late endosome.
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S3B and S3C). Moreover, when expressed together with HA-
Yki, Mop can retard Yki-driven transcriptional upregulation of
ex (Figure S3C).
We next examined whether mop loss in imaginal disc tissue
affects endosomal distribution of endogenous Yki. In control
H99 clones, Yki localizes to punctate cytoplasmic structures
that occasionally colocalize with early endosomal antigen-1
(EEA1)-positive early endosomes (Figures 6F–6H). InmopsfvH99
mutant tissue, EEA1-positive endosomes are more abundant
and tend to be larger than in control cells (red arrows in Figures
6H and 6K). Yki also accumulates in punctate structures in
mopsfvH99 that substantially overlap with enlarged EEA1-posi-
tive endosomes (Figures 6I–6K). The extent of Yki:EEA1 colocal-
ization was quantitated by counting the percentage of EEA1-
positive endosomes of all sizes that are also positive for Yki. In
H99 control clones, the percentage of EEA1/Yki-positive endo-
somes is 19% ± 2% (compiled from ten clones containing a total
of 380 EEA1-positive endosomes). In mopsfvH99 tissue this
approximately doubles to 38% ± 3% (compiled from ten clones
containing a total of 584 EEA1-positive endosomes). To deter-
mine whether this enrichment of Yki in EEA1 endosomes is
accompanied by changes in localization of Yki on late endo-
somes, the association of Yki with Rab7-positive late endo-
somes was examined in H99 and mopsfvH99 clones. In H99
control clones, Yki localizes to structures that are adjacent to
but do not substantially overlap with Rab7 late endosomes
(Figures S4E and S4E00). mopsfvH99 clones contain enlarged
Rab7-positive endosomes that exclude the increased pool ofDevelopmental Cell 20cytoplasmic endogenous Yki (Figures S4D and
S4D00). Thus, mop loss in imaginal disc tissue
leads to an increase in the early-endosome-
associated pool of cytoplasmic Yki.
Mop Restricts Ectopic ex but Not diap1
Transcription in Imaginal Discs
Yki lacks DNA binding activity but has been
shown to activate transcription of the diap1
promoter via the DNA binding factor and TEAD
homolog Scalloped (Sd) (Goulev et al., 2008;
Wu et al., 2008; Zhang et al., 2008). Interest-ingly, qRT-PCR analysis shows that mopsfvH99 mutant discs
elevated expression of ex mRNA transcripts but not diap1 tran-
scripts, while wts mutant cells elevated levels of both ex and
diap1 transcripts (Figure 7B). In addition, DIAP1 protein is not
elevated in mopsfvH99 mutant clones (Figures 7A and 7A0) but
is readily detected at elevated levels in wts mutant eye disc
clones (Figures S4A and S4A0). diap1-lacZ (th-Z) reporter expres-
sion is also unaffected in mopsfvH99 mutant eye clones marked
by upregulated Crb (Figures S4B and S4B0). The lack of an effect
on diap1 indicates that Mop may be required to regulate the
expression of some SWH targets and not others. To test this,
MARCM analysis was used to analyze SWH target gene
induction in wts mutant clones overexpressing Mop. As previ-
ously reported (Hamaratoglu et al., 2006), ex-Z and th-Z are
strongly upregulated in wts mutant clones (Figures 7C, 7C0,
7D, and 7D0). Overexpression of wild-type Mop rescues the
effect ofwts loss on ex-Z (Figures 7E and 7E0) but does not block
elevated th-Z expression (Figures 7F and 7F0). The catalytic site
mutant form of MopCS (Miura et al., 2008) was also able to
efficiently suppress ectopic ex-Z levels in wts clones (Figures
7G and 7G0). These data suggest that Mop acts to restrict
Yki-driven upregulation of ex transcription but not diap1 tran-
scription and that it does so through a mechanism that does
not require Mop catalytic tyrosine phosphatase activity.
DISCUSSION
Here, we describe a screening strategy to identify mutations in
Drosophila that require a synergistic block in cell death in order, 700–712, May 17, 2011 ª2011 Elsevier Inc. 707
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identified the endosomal protein Mop, which is the Drosophila
homolog of the candidate mammalian tumor suppressor
HD-PTP, as a regulator of the SWH growth inhibitory pathway.
Through multiple approaches, we demonstrate that Mop regu-
lates Yki activity via a mechanism involving direct binding and
modulation of Yki endosomal association.
This study defines a pool of cytoplasmic Yki that binds Mop
and colocalizes with it on endosomes. Data from discs and
cultured cells indicate Mop controls endosomal association of
this pool of Yki and that a positive correlation exists between
Yki colocalization with EEA1-positive early endosomes and Yki
levels and activity. A growing body of genetic and molecular
data support a role for endosomes as key signaling centers for
signal transduction pathways that influence the nuclear translo-
cation of latent cytoplasmic transcription factors (Birtwistle and
Kholodenko, 2009; Bokel et al., 2006; Devergne et al., 2007;
Di Guglielmo et al., 2003; Fortini and Bilder, 2009) (for review,
see Miaczynska et al., 2004; Murphy et al., 2009; Taelman
et al., 2010). For example, the activated c-Met receptor associ-
ates with the STAT3 transcription factor on EEA1-positive endo-
somes prior to STAT3 nuclear accumulation, and c-Met delivery
to a perinuclear endosomal compartment is necessary to sustain
nuclear STAT3 (Kermorgant and Parker, 2008). The enrichment
of Yki on EEA1 endosomes and activation of a subset of Yki
nuclear targets in mop mutant cells suggests that Yki, perhaps
in association with receptor complexes, may take a similar route
to the nucleus. Intriguingly, microtubule-regulated perinuclear
transport of Merlin (Mer) controls nucleocytoplasmic shuttling
of Yki (Bensenor et al., 2010). The direct link between Mer trans-
port and Yki shuttling is not clear. However, as Mer can control
internalization of transmembrane receptors (for review, see
McClatchey and Fehon, 2009), perinuclear transport of Mer
might in turn modulate endosomal internalization and transit of
Yki:receptor complexes en route to the nucleus.
Genetic data show that exogenous Mop is sufficient to restrict
ectopic expression of the Yki-target ex but not diap1 and that
loss of endogenous Mop upregulates a set of Yki targets that
do not include diap1. Mop thus appears to define a regulatory
step in determining outputs of the SWH pathway, perhaps as
part of the endosomal sorting process. Trafficking of transmem-
brane proteins down alternate endosomal routes contributes to
the activation of different nuclear programs in the Notch,
Jak/STAT, and Akt pathways (Hori et al., 2004; Kermorgant
and Parker, 2008; Schenck et al., 2008). Similarly, association
of Yki-containing complexes with different endosomal compart-
ments may shift Yki nuclear output, perhaps by bringing Yki into
contact with posttranslational modifiers or binding partners that
affect its ability to activate its suite of target promoters. Further
studies will be required to establish whether loss of Mop indeed
alters Yki posttranslational modification or the assembly of Yki
transcriptional complexes.
In the context of SWH signaling, the differential effect of mop
loss on ex and diap1 expression place Mop within the growth
regulatory arm of the SWH network. Differential effects on the
growth and apoptotic outputs of the SWH pathway is also
a feature of mutations in ex and mer, which preferentially drive
Yki-dependent clonal growth or antiapoptotic signals, respec-
tively (Pellock et al., 2007) and whose combined mutant pheno-708 Developmental Cell 20, 700–712, May 17, 2011 ª2011 Elsevier Intypes are more severe than those of single mutants (Hamarato-
glu et al., 2006; Maitra et al., 2006). The synergy between ex and
mop alleles on IOC number extends this model and supports the
hypothesis that Ex is downstream of wts in growth control but
upstream of wts in apoptotic control (Badouel et al., 2009;
Hamaratoglu et al., 2006).
mop mutant cells undergo high rates of caspase-dependent
apoptosis in developing eye and wing imaginal discs (this study
and Miura et al., 2008). It is probable that this apoptosis is not
caused by an effect on diap1 expression but rather a requirement
for Mop in additional prosurvival mechanisms. Knockdown of
vertebrate HD-PTP/PTPN23 elevates levels of tyrosine phos-
phorylated focal adhesion kinase (FAK) (Castiglioni et al.,
2007), which is implicated in cell migration and integrin-mediated
survival signals (Mitra and Schlaepfer, 2006). Mop facilitates traf-
ficking of the EGFR receptor into late endosomal compartments
and promotes Ras/MAPK signaling downstream of EGFR in the
developing retina (Miura et al., 2008). Because the Ras/MAPK
module is required to restrain cell death pathways (e.g., Berg-
mann et al., 1998; Kurada and White, 1998), reduced EGFR-
dependent signaling seems likely to contribute to a subset of
the apoptotic phenotype of mop mutant cells.
The Mop:Yki interaction involves a WW:PPxY interaction
mechanism shared by the SWH proteins Ex, Wts, and Hpo that
can bind Yki directly and regulate its activity independent of
S168 phosphorylation status (Badouel et al., 2009; Oh et al.,
2009). Mop represses growth driven by the YkiS3A mutant, indi-
cating that its repressive mechanism is not dependent on Wts
kinase activity. As Mop controls the distribution of Yki across
endosomal compartments, the paired Bro1 and PPxY domains
in Mop could function as a bridge between Yki-containing
SWH signaling complexes in the cytoplasm and complexes on
the outer membrane of endosomes such as ESCRTs. These
complexes could be fairly static or they could assemble and
disassemble in response to specific signals. The fact that Mop,
Ex, Hpo, and Wts share a WW:PPxY binding mechanism
suggests these proteins might compete for Yki binding in the
cytosol, or that Mop acts as an endocytic scaffolding factor in
a ‘‘hand-off’’ mechanism from the upstream components Ex,
Hpo, andWts. Indeed, understanding the dynamics and compo-
sition of the Mop:Yki complex is a significant question going
forward. Intriguingly, loss of the Lgl kinase, which regulates cell
polarity and membrane compartmentalization (Bilder, 2004),
elevates Yki activity by mislocalizing Hpo and the SWH com-
ponent RASSF in the cytoplasm of disc cells (Grzeschik et al.,
2010), suggesting that Hpo and RASSF proteins participate in
dynamic and localized interactions in the cytoplasm that are
important for their Yki-regulatory function.
The human HD-PTP/PTPN23 gene resides in a region of the
genome (3p21.3) associated with loss of heterozygosity (LOH)
in greater than 90% of small cell (SCLC) and non-small-cell
(NSCLC) lung cancers (Braga et al., 2002; Kok et al., 1997;
Szeles et al., 1997; Toyooka et al., 2000). Yap protein is predom-
inantly nuclear in a subset of primary NSCLC samples and
promotes cell proliferation and invasion in NSCLC cell lines,
and its expression correlates with poor prognosis in NSCLC
patients (Wang et al., 2010). Thus, mutations that deregulate
Yap levels and activity are predicted to promote the inappro-
priate growth and invasiveness of lung epithelial cells. Thec.
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its ability to suppress colony formation of human renal cancer
cells is independent of catalytic PTPase activity (Gingras et al.,
2009) in much the same way that regulation of Yki by Mop
does not require PTPase activity. Although HD-PTP lacks
a canonical PPxY motif, genetic data indicate that Mop retains
the ability to inhibit Yap activity in the Drosophila eye. The extent
to which HD-PTP binds Yap or Taz has yet to be examined, but if
the relationship between the orthologous Drosophila proteins is
conserved in vertebrates, this link to Yki/Yap may contribute to
growth regulatory roles of vertebrate HD-PTP proteins in devel-
opment and disease.EXPERIMENTAL PROCEDURES
Drosophila Genetics
Alleles used: ex697 (ex-Z) (Boedigheimer et al., 1993), thj5c8 (th-Z) (Hay et al.,
1995), ykiB5 (Huang et al., 2005), wtsX1 (Xu et al., 1995), and H99 (White
et al., 1994). Transgenes used: UAS-Myc-Wts1 (Jia et al., 2003), UAS-Ex
(Boedigheimer et al., 1997), UAS-Mop and UAS-MopCS (Miura et al., 2008),
UAS-Yki:V5 (Oh and Irvine, 2009),UAS-mopIR (ViennaDrosophilaRNAi Collec-
tion), and bantam-GFP (Brennecke et al., 2003).
Immunofluorescence
Imaginal discs and S2 cells were fixed and stained following standard proce-
dures. Antibodies used: mouse anti-Dlg (1:20, DSHB), mouse anti-BrdU (1:50,
Becton Dickinson), mouse anti-cyclin E (1:5, H. Richardson), mouse anti-cyclin
A (1:200, DSHB), guinea pig anti-Expanded (1:10,000, R. Fehon), rat anti-Crb
(1:500, U. Tepass), mouse anti-Wg (1:800, DSHB), mouse anti-b-galactosi-
dase (1:1000, Promega), mouse anti-V5 (1:200, Invitrogen) andmouse anti-HA
High Affinity (1:100, Roche), mouse anti-Yki (1:100, Zhi-Chun Lai), rabbit anti-
EEA1 (1:250, Thermo-Scientific), and mouse anti-DIAP1 (1:400, B. Hay).
Clonal Cell Counts and Cell-Cycle Analysis
For FACS analysis,H99/M(3) andmopsfvH99/M(3)wing discs were dissociated
in PBS Trypsin-EDTA and stained with 20 mM DRAQ-5 (Biostatus Limited).
Data were acquired on a Becton Dickinson LSR II flow cytometer and analyzed
with FlowJo Software. Clonal cell count data were generated by producing
heat-shocked H99 and mopsfvH99 wing clones 48 hr AED. At 96 AED, wing
discs were fixed and stained with DRAQ5, and the number of nuclei per clone
and twin-spot pair was counted.
Quantitative RT-PCR
Total RNA was extracted from larval eye discs using TRizol (Invitrogen) and
purified using RNeasy Mini Kit (QIAGEN). Superscript II RT and random
primers (Invitrogen) were used to produce cDNAs. Exon-specific primers
were usedwith SYBRGreen IMaster (Roche) to perform qPCR reactions using
a Roche LightCycler 480. All reactions were performed in triplicate, and the
relative amount of diap1 and exmRNA was normalized to b-tubulin transcript.
Cell Culture
Drosophila S2 cells were maintained at 25C in Schneider’s Drosophila
medium (GIBCO) supplemented with 10% heat-inactivated fetal bovine serum
(GIBCO). Proteins were induced with 0.35 mM CuSO4 overnight. To establish
a stable cell line of pMK33-GSNTAP-MopCS, S2 cells were transfected using
Effectene transfection reagent (QIAGEN). After 48 hr of incubation with the
transfection reagent, cells were maintained in complete media with
300 mg/ml hygromycin (Sigma).mop dsRNA was generated using the T7 Ribo-
MAX system (Promega) using the following primers: 50-T7-TGCCCACATTA
CCGAGTTATCG-30 and 50-T7-TTTCCGCTATTGGTTTGCTGAC-30. mop
dsRNA was transfected into cells using Cellfectin (Invitrogen), and cells were
incubated for 48 hr, followed by transfection with the following constructs:
(1) pAc5.1-Yki:V5, (2) UAS-GFP:Rab5, (3) UAS-GFP:Rab7, (4) pMT-Gal4,
followed by another 48 hr incubation and inductionwith 0.5mMCuSO4 for 4 hr.DeveImmunoprecipitation
Cell extracts were lysed in lysis buffer (LB: 50 mM Tris [pH 7.5], 125 mM NaCl,
5% glycerol, 0.2% IGEPAL, 1.5 mM MgCl2, 1 mM DTT, 25 mM NaF, 1 mM
Na3VO4, 1 mM EDTA, and complete protease inhibitor [Roche]), and lysates
were incubated with anti-HA affinity beads (Sigma) for 2 hr at 4C, followed
by extensive washes. Protein complexes were eluted with SDS sample buffer,
separated on SDS protein gels, transferred onto Immun-Blot PVDF
membranes (Bio-Rad), and probed with mouse anti-HA or mouse anti-V5 anti-
bodies (Sigma).
SUPPLEMENTAL INFORMATION
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online at doi:10.1016/j.devcel.2011.04.012.
ACKNOWLEDGMENTS
We apologize to those who could not be cited due to space constraints. We
thank D.J. Pan, G. Halder, K. Irvine, K. Harvey, H. McNeill, Z.-C. Lai, J. Jiang,
Y. Chinchore, R. Fehon, J. Treisman, T. Xu, B. Hay, and M. Frolov for gifts of
reagents and fly stocks. We acknowledge the Vienna Drosophila RNAi Collec-
tion, the Harvard TRiP collection, the Bloomington Drosophila Stock Center,
and the Developmental Studies Hybridoma Bank (DSHB) for providing fly
stocks and antibodies. We thank members of the Moberg and Veraksa labo-
ratories for helpful comments and discussion, the Taplin Mass Spectrometry
Facility (Harvard University) for peptide analysis, and the Robert P. Apkarian
Integrated Electron Microscopy Core for SEM images. This work was sup-
ported by NIH CA1123368 to K.H.M. and NSF 0640700 to A.V.
Received: June 1, 2010
Revised: February 28, 2011
Accepted: April 26, 2011
Published: May 16, 2011
REFERENCES
Asano, M., Nevins, J.R., and Wharton, R.P. (1996). Ectopic E2F expression
induces S phase and apoptosis in Drosophila imaginal discs. Genes Dev.
10, 1422–1432.
Badouel, C., Gardano, L., Amin, N., Garg, A., Rosenfeld, R., Le Bihan, T., and
McNeill, H. (2009). The FERM-domain protein Expanded regulates Hippo
pathway activity via direct interactions with the transcriptional activator
Yorkie. Dev. Cell 16, 411–420.
Baumgartner, R., Poernbacher, I., Buser, N., Hafen, E., and Stocker, H. (2010).
The WW domain protein Kibra acts upstream of Hippo in Drosophila. Dev. Cell
18, 309–316.
Bennett, F.C., and Harvey, K.F. (2006). Fat cadherin modulates organ size in
Drosophila via the Salvador/Warts/Hippo signaling pathway. Curr. Biol. 16,
2101–2110.
Bensenor, L.B., Barlan, K., Rice, S.E., Fehon, R.G., and Gelfand, V.I. (2010).
Microtubule-mediated transport of the tumor-suppressor protein Merlin and
its mutants. Proc. Natl. Acad. Sci. USA 107, 7311–7316.
Bergmann, A., Agapite, J., McCall, K., and Steller, H. (1998). The Drosophila
gene hid is a direct molecular target of Ras-dependent survival signaling.
Cell 95, 331–341.
Bilder, D. (2004). Epithelial polarity and proliferation control: links from the
Drosophila neoplastic tumor suppressors. Genes Dev. 18, 1909–1925.
Birtwistle, M.R., and Kholodenko, B.N. (2009). Endocytosis and signalling:
a meeting with mathematics. Mol. Oncol. 3, 308–320.
Boedigheimer, M., Bryant, P., and Laughon, A. (1993). Expanded, a negative
regulator of cell proliferation in Drosophila, shows homology to the NF2 tumor
suppressor. Mech. Dev. 44, 83–84.
Boedigheimer, M.J., Nguyen, K.P., and Bryant, P.J. (1997). Expanded func-
tions in the apical cell domain to regulate the growth rate of imaginal discs.
Dev. Genet. 20, 103–110.lopmental Cell 20, 700–712, May 17, 2011 ª2011 Elsevier Inc. 709
Developmental Cell
Myopic Controls SWH Output by Binding to YorkieBokel, C., Schwabedissen, A., Entchev, E., Renaud, O., and Gonzalez-Gaitan,
M. (2006). Sara endosomes and the maintenance of Dpp signaling levels
across mitosis. Science 314, 1135–1139.
Braga, E., Senchenko, V., Bazov, I., Loginov, W., Liu, J., Ermilova, V.,
Kazubskaya, T., Garkavtseva, R., Mazurenko, N., Kisseljov, F., et al. (2002).
Critical tumor-suppressor gene regions on chromosome 3P in major human
epithelial malignancies: allelotyping and quantitative real-time PCR. Int. J.
Cancer 100, 534–541.
Brennecke, J., Hipfner, D.R., Stark, A., Russell, R.B., and Cohen, S.M. (2003).
bantam encodes a developmentally regulated microRNA that controls cell
proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113,
25–36.
Brumby, A.M., and Richardson, H.E. (2005). Using Drosophila melanogaster to
map human cancer pathways. Nat. Rev. Cancer 5, 626–639.
Castiglioni, S., Maier, J.A., and Mariotti, M. (2007). The tyrosine phosphatase
HD-PTP: A novel player in endothelial migration. Biochem. Biophys. Res.
Commun. 364, 534–539.
Chen, C.L., Gajewski, K.M., Hamaratoglu, F., Bossuyt, W., Sansores-Garcia,
L., Tao, C., and Halder, G. (2010). The apical-basal cell polarity determinant
Crumbs regulates Hippo signaling in Drosophila. Proc. Natl. Acad. Sci. USA
107, 15810–15815.
Chi, C., Zhu, H., Han, M., Zhuang, Y., Wu, X., and Xu, T. (2010). Disruption of
lysosome function promotes tumor growth and metastasis in Drosophila.
J. Biol. Chem. 285, 21817–21823.
Cho, E., Feng, Y., Rauskolb, C., Maitra, S., Fehon, R., and Irvine, K.D. (2006).
Delineation of a Fat tumor suppressor pathway. Nat. Genet. 38, 1142–1150.
Devergne, O., Ghiglione, C., and Noselli, S. (2007). The endocytic control of
JAK/STAT signalling in Drosophila. J. Cell Sci. 120, 3457–3464.
Di Guglielmo, G.M., Le Roy, C., Goodfellow, A.F., and Wrana, J.L. (2003).
Distinct endocytic pathways regulate TGF-beta receptor signalling and turn-
over. Nat. Cell Biol. 5, 410–421.
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S.A.,
Gayyed, M.F., Anders, R.A., Maitra, A., and Pan, D. (2007). Elucidation of
a universal size-control mechanism in Drosophila and mammals. Cell 130,
1120–1133.
Doyotte, A., Mironov, A., McKenzie, E., and Woodman, P. (2008). The Bro1-
related protein HD-PTP/PTPN23 is required for endosomal cargo sorting
and multivesicular body morphogenesis. Proc. Natl. Acad. Sci. USA 105,
6308–6313.
Evan, G.I., and Vousden, K.H. (2001). Proliferation, cell cycle and apoptosis in
cancer. Nature 411, 342–348.
Fortini, M.E., and Bilder, D. (2009). Endocytic regulation of Notch signaling.
Curr. Opin. Genet. Dev. 19, 323–328.
Genevet, A., Polesello, C., Blight, K., Robertson, F., Collinson, L.M., Pichaud,
F., and Tapon, N. (2009). The Hippo pathway regulates apical-domain size
independently of its growth-control function. J. Cell Sci. 122, 2360–2370.
Genevet, A., Wehr, M.C., Brain, R., Thompson, B.J., and Tapon, N. (2010).
Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev. Cell
18, 300–308.
Gingras, M.C., Zhang, Y.L., Kharitidi, D., Barr, A.J., Knapp, S., Tremblay, M.L.,
and Pause, A. (2009). HD-PTP is a catalytically inactive tyrosine phosphatase
due to a conserved divergence in its phosphatase domain. PLoS ONE 4,
e5105.
Goulev, Y., Fauny, J.D., Gonzalez-Marti, B., Flagiello, D., Silber, J., and Zider,
A. (2008). SCALLOPED interacts with YORKIE, the nuclear effector of the
hippo tumor-suppressor pathway in Drosophila. Curr. Biol. 18, 435–441.
Grzeschik, N.A., Parsons, L.M., Allott, M.L., Harvey, K.F., andRichardson, H.E.
(2010). Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway
through two distinct mechanisms. Curr. Biol. 20, 573–581.
Halder, G., and Johnson, R.L. (2011). Hippo signaling: growth control and
beyond. Development 138, 9–22.
Hamaratoglu, F., Willecke, M., Kango-Singh, M., Nolo, R., Hyun, E., Tao, C.,
Jafar-Nejad, H., and Halder, G. (2006). The tumour-suppressor genes NF2/710 Developmental Cell 20, 700–712, May 17, 2011 ª2011 Elsevier InMerlin and Expanded act through Hippo signalling to regulate cell proliferation
and apoptosis. Nat. Cell Biol. 8, 27–36.
Hamaratoglu, F., Gajewski, K., Sansores-Garcia, L., Morrison, C., Tao, C., and
Halder, G. (2009). The Hippo tumor-suppressor pathway regulates apical-
domain size in parallel to tissue growth. J. Cell Sci. 122, 2351–2359.
Harvey, K.F., Pfleger, C.M., and Hariharan, I.K. (2003). The Drosophila Mst
ortholog, hippo, restricts growth and cell proliferation and promotes
apoptosis. Cell 114, 457–467.
Hay, B.A., Wassarman, D.A., and Rubin, G.M. (1995). Drosophila homologs of
baculovirus inhibitor of apoptosis proteins function to block cell death. Cell 83,
1253–1262.
Hori, K., Fostier, M., Ito, M., Fuwa, T.J., Go, M.J., Okano, H., Baron, M., and
Matsuno, K. (2004). Drosophila deltex mediates suppressor of Hairless-inde-
pendent and late-endosomal activation of Notch signaling. Development
131, 5527–5537.
Huang, J., Wu, S., Barrera, J., Matthews, K., and Pan, D. (2005). The Hippo
signaling pathway coordinately regulates cell proliferation and apoptosis by in-
activating Yorkie, the Drosophila Homolog of YAP. Cell 122, 421–434.
Huang, H.R., Chen, Z.J., Kunes, S., Chang, G.D., and Maniatis, T. (2010).
Endocytic pathway is required for Drosophila Toll innate immune signaling.
Proc. Natl. Acad. Sci. USA 107, 8322–8327.
Ichioka, F., Takaya, E., Suzuki, H., Kajigaya, S., Buchman, V.L., Shibata, H.,
and Maki, M. (2007). HD-PTP and Alix share some membrane-traffic related
proteins that interact with their Bro1 domains or proline-rich regions. Arch.
Biochem. Biophys. 457, 142–149.
Jia, J., Zhang, W., Wang, B., Trinko, R., and Jiang, J. (2003). The Drosophila
Ste20 family kinase dMST functions as a tumor suppressor by restricting
cell proliferation and promoting apoptosis. Genes Dev. 17, 2514–2519.
Justice, R.W., Zilian, O., Woods, D.F., Noll, M., and Bryant, P.J. (1995). The
Drosophila tumor suppressor gene warts encodes a homolog of human
myotonic dystrophy kinase and is required for the control of cell shape and
proliferation. Genes Dev. 9, 534–546.
Kango-Singh, M., Nolo, R., Tao, C., Verstreken, P., Hiesinger, P.R., Bellen,
H.J., and Halder, G. (2002). Shar-pei mediates cell proliferation arrest during
imaginal disc growth in Drosophila. Development 129, 5719–5730.
Kermorgant, S., and Parker, P.J. (2008). Receptor trafficking controls weak
signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation.
J. Cell Biol. 182, 855–863.
Kim, J., Sitaraman, S., Hierro, A., Beach, B.M., Odorizzi, G., and Hurley, J.H.
(2005). Structural basis for endosomal targeting by the Bro1 domain. Dev.
Cell 8, 937–947.
Kok, K., Naylor, S.L., and Buys, C.H. (1997). Deletions of the short arm of chro-
mosome 3 in solid tumors and the search for suppressor genes. Adv. Cancer
Res. 71, 27–92.
Kurada, P., and White, K. (1998). Ras promotes cell survival in Drosophila by
downregulating hid expression. Cell 95, 319–329.
Kyriakakis, P., Tipping, M., Abed, L., and Veraksa, A. (2008). Tandem affinity
purification in Drosophila: the advantages of the GS-TAP system. Fly (Austin)
2, 229–235.
Lai, Z.C., Wei, X., Shimizu, T., Ramos, E., Rohrbaugh, M., Nikolaidis, N., Ho,
L.L., and Li, Y. (2005). Control of cell proliferation and apoptosis by mob as
tumor suppressor, mats. Cell 120, 675–685.
Levy, D., Adamovich, Y., Reuven, N., and Shaul, Y. (2008). Yap1 phosphoryla-
tion by c-Abl is a critical step in selective activation of proapoptotic genes in
response to DNA damage. Mol. Cell 29, 350–361.
Ling, C., Zheng, Y., Yin, F., Yu, J., Huang, J., Hong, Y., Wu, S., and Pan, D.
(2010). The apical transmembrane protein Crumbs functions as a tumor
suppressor that regulates Hippo signaling by binding to Expanded. Proc.
Natl. Acad. Sci. USA 107, 10532–10537.
Maitra, S., Kulikauskas, R.M., Gavilan, H., and Fehon, R.G. (2006). The tumor
suppressors Merlin and Expanded function cooperatively to modulate
receptor endocytosis and signaling. Curr. Biol. 16, 702–709.c.
Developmental Cell
Myopic Controls SWH Output by Binding to YorkieMatakatsu, H., and Blair, S.S. (2008). The DHHC palmitoyltransferase approx-
imated regulates Fat signaling and Dachs localization and activity. Curr. Biol.
18, 1390–1395.
McClatchey, A.I., and Fehon, R.G. (2009). Merlin and the ERM proteins–regu-
lators of receptor distribution and signaling at the cell cortex. Trends Cell Biol.
19, 198–206.
Miaczynska, M., Pelkmans, L., and Zerial, M. (2004). Not just a sink: endo-
somes in control of signal transduction. Curr. Opin. Cell Biol. 16, 400–406.
Mitra, S.K., and Schlaepfer, D.D. (2006). Integrin-regulated FAK-Src signaling
in normal and cancer cells. Curr. Opin. Cell Biol. 18, 516–523.
Miura, G.I., Roignant, J.Y., Wassef, M., and Treisman, J.E. (2008). Myopic acts
in the endocytic pathway to enhance signaling by the Drosophila EGF
receptor. Development 135, 1913–1922.
Murphy, J.E., Padilla, B.E., Hasdemir, B., Cottrell, G.S., and Bunnett, N.W.
(2009). Endosomes: a legitimate platform for the signaling train. Proc. Natl.
Acad. Sci. USA 106, 17615–17622.
Newsome, T.P., Asling, B., and Dickson, B.J. (2000). Analysis of Drosophila
photoreceptor axon guidance in eye-specific mosaics. Development 127,
851–860.
Nicholson, S.C., Gilbert, M.M., Nicolay, B.N., Frolov, M.V., and Moberg, K.H.
(2009). The archipelago tumor suppressor gene limits Rb/E2F-regulated
apoptosis in developing drosophila tissues. Curr. Biol. 19, 1503–1510.
Odorizzi, G., Katzmann, D.J., Babst, M., Audhya, A., and Emr, S.D. (2003).
Bro1 is an endosome-associated protein that functions in the MVB pathway
in Saccharomyces cerevisiae. J. Cell Sci. 116, 1893–1903.
Oh, H., and Irvine, K.D. (2008). In vivo regulation of Yorkie phosphorylation and
localization. Development 135, 1081–1088.
Oh, H., and Irvine, K.D. (2009). In vivo analysis of Yorkie phosphorylation sites.
Oncogene 28, 1916–1927.
Oh, H., and Irvine, K.D. (2011). Cooperative regulation of growth by Yorkie and
Mad through bantam. Dev. Cell 20, 109–122.
Oh, H., Reddy, B.V., and Irvine, K.D. (2009). Phosphorylation-independent
repression of Yorkie in Fat-Hippo signaling. Dev. Biol. 335, 188–197.
Pagliarini, R.A., and Xu, T. (2003). A genetic screen in Drosophila for metastatic
behavior. Science 302, 1227–1231.
Pan, D. (2010). The hippo signaling pathway in development and cancer. Dev.
Cell 19, 491–505.
Pantalacci, S., Tapon, N., and Leopold, P. (2003). The Salvador partner Hippo
promotes apoptosis and cell-cycle exit in Drosophila. Nat. Cell Biol. 5,
921–927.
Pellock, B.J., Buff, E., White, K., and Hariharan, I.K. (2007). The Drosophila
tumor suppressors Expanded and Merlin differentially regulate cell cycle
exit, apoptosis, and Wingless signaling. Dev. Biol. 304, 102–115.
Peng, H.W., Slattery, M., and Mann, R.S. (2009). Transcription factor choice in
the Hippo signaling pathway: homothorax and yorkie regulation of the
microRNA bantam in the progenitor domain of the Drosophila eye imaginal
disc. Genes Dev. 23, 2307–2319.
Reddy, B.V., and Irvine, K.D. (2008). The Fat and Warts signaling pathways:
new insights into their regulation, mechanism and conservation.
Development 135, 2827–2838.
Ren, F., Zhang, L., and Jiang, J. (2010). Hippo signaling regulates Yorkie
nuclear localization and activity through 14-3-3 dependent and independent
mechanisms. Dev. Biol. 337, 303–312.
Robinson, B.S., Huang, J., Hong, Y., and Moberg, K.H. (2010). Crumbs regu-
lates Salvador/Warts/Hippo signaling in Drosophila via the FERM-domain
protein expanded. Curr. Biol. 20, 582–590.
Schenck, A., Goto-Silva, L., Collinet, C., Rhinn, M., Giner, A., Habermann, B.,
Brand, M., and Zerial, M. (2008). The endosomal protein Appl1 mediates Akt
substrate specificity and cell survival in vertebrate development. Cell 133,
486–497.
Silva, E., Tsatskis, Y., Gardano, L., Tapon, N., and McNeill, H. (2006). The
tumor-suppressor gene fat controls tissue growth upstream of expanded in
the hippo signaling pathway. Curr. Biol. 16, 2081–2089.DeveStaehling-Hampton, K., Ciampa, P.J., Brook, A., and Dyson, N. (1999). A
genetic screen for modifiers of E2F in Drosophila melanogaster. Genetics
153, 275–287.
Strano, S., Monti, O., Pediconi, N., Baccarini, A., Fontemaggi, G., Lapi, E.,
Mantovani, F., Damalas, A., Citro, G., Sacchi, A., et al. (2005). The transcrip-
tional coactivator Yes-associated protein drives p73 gene-target specificity
in response to DNA Damage. Mol. Cell 18, 447–459.
Szeles, A., Yang, Y., Sandlund, A.M., Kholodnyuk, I., Kiss, H., Kost-Alimova,
M., Zabarovsky, E.R., Stanbridge, E., Klein, G., and Imreh, S. (1997).
Human/mouse microcell hybrid based elimination test reduces the putative
tumor suppressor region at 3p21.3 to 1.6 cM. Genes Chromosomes Cancer
20, 329–336.
Taelman, V.F., Dobrowolski, R., Plouhinec, J.L., Fuentealba, L.C., Vorwald,
P.P., Gumper, I., Sabatini, D.D., and De Robertis, E.M. (2010). Wnt signaling
requires sequestration of glycogen synthase kinase 3 inside multivesicular
endosomes. Cell 143, 1136–1148.
Tapia, V.E., Nicolaescu, E., McDonald, C.B., Musi, V., Oka, T., Inayoshi, Y.,
Satteson, A.C., Mazack, V., Humbert, J., Gaffney, C.J., et al. (2010). Y65C
missense mutation in the WW domain of the Golabi-Ito-Hall syndrome protein
PQBP1 affects its binding activity and deregulates pre-mRNA splicing. J. Biol.
Chem. 285, 19391–19401.
Tapon, N., Harvey, K.F., Bell, D.W., Wahrer, D.C.R., Schiripo, T.A., Haber,
D.A., and Hariharan, I.K. (2002). salvador Promotes Both Cell Cycle Exit and
Apoptosis in Drosophila and Is Mutated in Human Cancer Cell Lines. Cell
110, 467–478.
Toyooka, S., Ouchida, M., Jitsumori, Y., Tsukuda, K., Sakai, A., Nakamura, A.,
Shimizu, N., and Shimizu, K. (2000). HD-PTP: A novel protein tyrosine phos-
phatase gene on human chromosome 3p21.3. Biochem. Biophys. Res.
Commun. 278, 671–678.
Udan, R.S., Kango-Singh, M., Nolo, R., Tao, C., and Halder, G. (2003). Hippo
promotes proliferation arrest and apoptosis in the Salvador/Warts pathway.
Nat. Cell Biol. 5, 914–920.
Veraksa, A., Bauer, A., and Artavanis-Tsakonas, S. (2005). Analyzing protein
complexes in Drosophila with tandem affinity purification-mass spectrometry.
Dev. Dyn. 232, 827–834.
Wang, Y., Dong, Q., Zhang, Q., Li, Z., Wang, E., and Qiu, X. (2010).
Overexpression of yes-associated protein contributes to progression and
poor prognosis of non-small-cell lung cancer. Cancer Sci. 101, 1279–1285.
Wei, X., Shimizu, T., and Lai, Z.C. (2007). Mob as tumor suppressor is activated
by Hippo kinase for growth inhibition in Drosophila. EMBO J. 26, 1772–1781.
White, K., Grether, M.E., Abrams, J.M., Young, L., Farrell, K., and Steller, H.
(1994). Genetic control of programmed cell death in Drosophila. Science
264, 677–683.
Willecke, M., Hamaratoglu, F., Kango-Singh, M., Udan, R., Chen, C.L., Tao,
C., Zhang, X., and Halder, G. (2006). The fat cadherin acts through the hippo
tumor-suppressor pathway to regulate tissue size. Curr. Biol. 16, 2090–2100.
Wolff, T., and Ready, D.F. (1993). Pattern formation in the Drosophila retina. In
The Development of Drosophila melanogaster, M. Bate and A. Martinez Arias,
eds. (Plainview, NY: Cold Spring Harbor Laboratory Press), pp. 1277–1325.
Wu, S., Huang, J., Dong, J., and Pan, D. (2003). hippo encodes a Ste-20 family
protein kinase that restricts cell proliferation and promotes apoptosis in
conjunction with salvador and warts. Cell 114, 445–456.
Wu, S., Liu, Y., Zheng, Y., Dong, J., and Pan, D. (2008). The TEAD/TEF family
protein Scalloped mediates transcriptional output of the Hippo growth-regula-
tory pathway. Dev. Cell 14, 388–398.
Wu, M., Pastor-Pareja, J.C., and Xu, T. (2010). Interaction between Ras(V12)
and scribbled clones induces tumour growth and invasion. Nature 463,
545–548.
Xu, T., Wang,W., Zhang, S., Stewart, R.A., and Yu,W. (1995). Identifying tumor
suppressors in genetic mosaics: the Drosophila lats gene encodes a putative
protein kinase. Development 121, 1053–1063.
Yu, J., Zheng, Y., Dong, J., Klusza, S., Deng, W.M., and Pan, D. (2010). Kibra
functions as a tumor suppressor protein that regulates Hippo signaling in
conjunction with Merlin and Expanded. Dev. Cell 18, 288–299.lopmental Cell 20, 700–712, May 17, 2011 ª2011 Elsevier Inc. 711
Developmental Cell
Myopic Controls SWH Output by Binding to YorkieZaidi, S.K., Sullivan, A.J., Medina, R., Ito, Y., van Wijnen, A.J., Stein, J.L., Lian,
J.B., and Stein, G.S. (2004). Tyrosine phosphorylation controls Runx2-medi-
ated subnuclear targeting of YAP to repress transcription. EMBO J. 23,
790–799.
Zhang, L., Ren, F., Zhang, Q., Chen, Y., Wang, B., and Jiang, J. (2008). The
TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling
in organ size control. Dev. Cell 14, 377–387.712 Developmental Cell 20, 700–712, May 17, 2011 ª2011 Elsevier InZhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Lin, J.D., Wang, C.Y., Chinnaiyan,
A.M., Lai, Z.C., et al. (2008). TEAD mediates YAP-dependent gene induction
and growth control. Genes Dev. 22, 1962–1971.
Zhao, B., Li, L., Lei, Q., and Guan, K.L. (2010). The Hippo-YAP pathway in
organ size control and tumorigenesis: an updated version. Genes Dev. 24,
862–874.c.
